Literature DB >> 12125910

Splenectomy and ligation of the left gastric vein in schistosomiasis mansoni: the effect on esophageal variceal pressure measured by a non-invasive technique.

Cláudio Moura Lacerda1, Wilson Freire, Paulo Sergio Vieira de Melo, Heloisa Ramos Lacerda, Gustavo Carvalho.   

Abstract

The treatment of choice, in the Northeast of Brazil, of patients with a history of upper GI bleeding from ruptured esophageal varices (EV) and with hepatosplenomegaly secondary to schistosomiasis (HSS), is splenectomy and left gastric vein ligation (SLGL). However, the effect of this procedure on the EV pressure, the parameter that best correlates to re-bleeding risk, has not yet been evaluated. With the introduction of a minimally invasive technique to measure the EV pressure, it has become possible to assess the effect of this surgery without an increased risk to the patient. SLGL was performed in twenty two patients with a history of HSS and upper GI Bleeding secondary to esophageal varices. The non-invasive endoscopic pneumatic balloon was used to measure the EV pressure before surgery and the results were then compared with measurements made between five and eight days post-operatively. The pre-operative EV pressure ranged from 20.0 mmHg to 28.7 mmHg (mean 24.35 +/- 2.36 mmHg), with no correlation between the pressure and the calibre of the varices. In the post-operative period, a significant decrease in EV pressure was observed, ranging from 14.6 mmHg to 21.5 mmHg (mean 17.29 +/- 1.75 mmHg, p < 0.001). These results support the use of SLGL in patients with HSS and a history of variceal bleeding. The operation results in, at least for the short term and in the majority of cases, a reduction in the EV pressure, and therefore a reduced risk of repeating upper GI Bleeding.

Entities:  

Mesh:

Year:  2002        PMID: 12125910     DOI: 10.2302/kjm.51.89

Source DB:  PubMed          Journal:  Keio J Med        ISSN: 0022-9717


  6 in total

1.  Synchronous splenectomy and hepatectomy for patients with hepatocellular carcinoma and hypersplenism: A case-control study.

Authors:  Xiao-Yun Zhang; Chuan Li; Tian-Fu Wen; Lu-Nan Yan; Bo Li; Jia-Yin Yang; Wen-Tao Wang; Li Jiang
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

2.  Splenic artery ligature associated with endoscopic banding for schistosomal portal hypertension.

Authors:  Renata Potonyacz Colaneri; Fabrício Ferreira Coelho; Roberto de Cleva; Marcos Vinícius Perini; Paulo Herman
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

3.  Splenectomy Combined with Endoscopic Variceal Ligation (EVL) versus EVL Alone for Secondary Prophylaxis of Variceal Bleeding in Hepatosplenic Schistosomiasis: A Retrospective Case-Control Study.

Authors:  Jolivet Auguste Rakotomalala; Chantelli Iamblaudiot Razafindrazoto; Nitah Harivony Randriamifidy; Behoavy Mahafaly Ralaizanaka; Sonny Maherison; Domoina Harivonjy Hasina Laingonirina; Mialitiana Rakotomaharo; Anjaramalala Sitraka Rasolonjatovo; Mamisoa Anicet Rakotovao; Andry Lalaina Rinà Rakotozafindrabe; Tovo Harimanana Rabenjanahary; Rija Fanantenantsoa; Soloniaina Hélio Razafimahefa; Rado Manitrala Ramanampamonjy
Journal:  Hepat Med       Date:  2022-05-18

4.  Surgical treatment of hepatocellular carcinoma with cirrhotic esophageal varices and hypersplenism: a 184 case report.

Authors:  Bin Jiang; Xiaoping Chen; Zhiyong Huang; Zhiwei Zhang; Songqing He; Shaofa Wang; Zaide Wu; Fazu Qiu
Journal:  Front Med China       Date:  2007-02-01

5.  Doppler ultrasound could predict varices progression and rebleeding after portal hypertension surgery: lessons from 146 EGDS and 10 years of follow-up.

Authors:  Fabio Gonçalves Ferreira; Maurício Alves Ribeiro; Maria de Fátima Santos; José César Assef; Luiz Arnaldo Szutan
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

6.  Simultaneous hepatectomy and splenectomy versus hepatectomy alone for hepatocellular carcinoma complicated by hypersplenism: a meta-analysis.

Authors:  Wei Li; Shi-Qiang Shen; Shan-Min Wu; Zu-Bing Chen; Chao Hu; Rui-Chen Yan
Journal:  Onco Targets Ther       Date:  2015-08-19       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.